Technologie-Atlas
Arzneimittelforschung mit Fläschchen und Tabletten im Labor

Projekt

More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making

While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world data (RWD) to contribute to the understanding of drug effects is increasingly realized. Evidence, based on RWD – real world evidence (RWE) - can contribute significantly to the ev…

While randomized controlled trials (RCTs) remain the mainstay in drug development, approval, and reimbursement, the potential of real world data (RWD) to contribute to the understanding of drug effects is increasingly realized. Evidence, based on RWD – real world evidence (RWE) - can contribute significantly to the evidence to support decision making throughout all phases of (clinical) drug development, as well as improve efficiency in design and conduct of clinical trial programs.

The aim of this project is to develop, implement and establish evidentiary standards and methods to address the data and evidentiary needs of regulatory authorities and HTA bodies towards a more efficient use of RWD for the development, registration and assessment of medicinal products in Europe (More-EUROPA).

Themengebiete

  • Gesundheit Gesundheit – Überblick über Forschungsprojekte, Patente und Akteure im TechnologieAtlas.

Hochschulen

Unternehmen

  • IQVIA SOLUTIONS B.V. IQVIA SOLUTIONS B.V. – Unternehmen mit Aktivitäten in Forschung und Innovation.